Literature DB >> 22441395

False-negative hepatitis B virus (HBV) surface antigen in a vaccinated dialysis patient with a high level of HBV DNA in the United States.

Matthew C Foy1, Chloe L Thio, Hyon S Hwang, Melissa Saulynas, James P Hamilton, Derek M Fine, Mohamed G Atta.   

Abstract

Screening with hepatitis B surface antigen (HBsAg) is highly recommended for at-risk individuals. Mutations in the HBsAg can result in an inability to detect the virus during routine screening. We describe a hemodialysis patient found to have high levels of hepatitis B virus (HBV) DNA and HBV antibody but negative HBsAg on two routine assays.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22441395      PMCID： PMC3346338          DOI： 10.1128/CVI.05696-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  20 in total

1.  Immunoassay detection of hepatitis B surface antigen mutants.

Authors:  P F Coleman; Y C Chen; I K Mushahwar
Journal:  J Med Virol       Date:  1999-09       Impact factor: 2.327

2.  HBV genotyping and analysis for unique mutations.

Authors:  Anna Ayres; Stephen Locarnini; Angeline Bartholomeusz
Journal:  Methods Mol Med       Date:  2004

Review 3.  Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact.

Authors:  Bernard Weber
Journal:  J Clin Virol       Date:  2005-02       Impact factor: 3.168

4.  High levels of serum hepatitis B virus DNA in patients with 'anti-HBc alone': role of HBsAg mutants.

Authors:  O Launay; J Masurel; A Servant-Delmas; A-L Basse-Guérineau; J-F Méritet; S Laperche; P Sogni; A R Rosenberg
Journal:  J Viral Hepat       Date:  2011-06-30       Impact factor: 3.728

5.  A mathematical model to estimate global hepatitis B disease burden and vaccination impact.

Authors:  Susan T Goldstein; Fangjun Zhou; Stephen C Hadler; Beth P Bell; Eric E Mast; Harold S Margolis
Journal:  Int J Epidemiol       Date:  2005-10-25       Impact factor: 7.196

6.  Vaccine-induced escape mutant of hepatitis B virus.

Authors:  W F Carman; A R Zanetti; P Karayiannis; J Waters; G Manzillo; E Tanzi; A J Zuckerman; H C Thomas
Journal:  Lancet       Date:  1990-08-11       Impact factor: 79.321

7.  Recommendations for preventing transmission of infections among chronic hemodialysis patients.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2001-04-27

8.  Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.

Authors:  M G Ghany; B Ayola; F G Villamil; R G Gish; S Rojter; J M Vierling; A S Lok
Journal:  Hepatology       Date:  1998-01       Impact factor: 17.425

9.  Occult hepatitis B virus infection in a North American adult hemodialysis patient population.

Authors:  Gerald Y Minuk; Dong Feng Sun; Rebecca Greenberg; Manna Zhang; Kimberly Hawkins; Julia Uhanova; Adam Gutkin; Kevin Bernstein; Antonio Giulivi; Carla Osiowy
Journal:  Hepatology       Date:  2004-11       Impact factor: 17.425

10.  Subtype ayw variant of hepatitis B virus. DNA primary structure analysis.

Authors:  V Bichko; P Pushko; D Dreilina; P Pumpen; E Gren
Journal:  FEBS Lett       Date:  1985-06-03       Impact factor: 4.124
View more
  8 in total

1.  Vaccinating the Patient with ESKD.

Authors:  Sana F Khan; Brendan T Bowman
Journal:  Clin J Am Soc Nephrol       Date:  2019-07-01       Impact factor: 8.237

Review 2.  Applications of human hepatitis B virus preS domain in bio- and nanotechnology.

Authors:  Riki Toita; Takahito Kawano; Jeong-Hun Kang; Masaharu Murata
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

3.  Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection.

Authors:  Luisa Romanò; Claudio Velati; Giuseppe Cambiè; Laura Fomiatti; Claudio Galli; Alessandro Remo Zanetti
Journal:  Blood Transfus       Date:  2013-01-23       Impact factor: 3.443

Review 4.  Clinical significance of hepatitis B surface antigen mutants.

Authors:  Nicola Coppola; Lorenzo Onorato; Carmine Minichini; Giovanni Di Caprio; Mario Starace; Caterina Sagnelli; Evangelista Sagnelli
Journal:  World J Hepatol       Date:  2015-11-28

5.  Durability of Antibody Response Against the Hepatitis B Virus in Kidney Transplant Recipients: A Proposed Immunization Guideline From a 3-Year Follow-up Clinical Study.

Authors:  Wiwat Chancharoenthana; Asada Leelahavanichkul; Suwasin Udomkarnjananun; Salin Wattanatorn; Yingyos Avihingsanon; Kearkiat Praditpornsilpa; Kriang Tungsanga; Somchai Eiam-Ong; Natavudh Townamchai
Journal:  Open Forum Infect Dis       Date:  2018-12-16       Impact factor: 3.835

Review 6.  A meta-analysis on genetic variability of RT/HBsAg overlapping region of hepatitis B virus (HBV) isolates of Bangladesh.

Authors:  Md Golzar Hossain; Keiji Ueda
Journal:  Infect Agent Cancer       Date:  2019-11-07       Impact factor: 2.965

7.  Reactivation of a Vaccine Escape Hepatitis B Virus Mutant in a Cambodian Patient During Anti-Hepatitis C Virus Therapy.

Authors:  Dahlene N Fusco; Lilia Ganova-Raeva; Yury Khudyakov; Lili Punkova; Aisha Mohamed; Scarlett Se Yun Cheon; Prapti Koirala; Karin L Andersson; Gonzague Jourdain; Camille Sureau; Raymond T Chung; Georg Lauer
Journal:  Front Med (Lausanne)       Date:  2018-04-30

8.  Hepatitis B Virus Mutant Infections in Hemodialysis Patients: A Case Series.

Authors:  Ibironke W Apata; Duc B Nguyen; Yury Khudyakov; Tonya Mixson-Hayden; Jon Rosenberg; Matt Zahn; Jane Greenko; Ernest Clement; Allison E Portney; Prathit A Kulkarni; Maura Comer; Eleanor Adams; Saleem Kamili; Priti R Patel; Anne C Moorman
Journal:  Kidney Med       Date:  2019-10-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.